Bariatric surgery and secondary hyperparathyroidism: a meta-analysis.

Surg Obes Relat Dis

Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Biliopancreatic and Metabolic Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Electronic address:

Published: January 2023

Background: Obesity increases the risk of obesity-related medical problems. Weight loss after metabolic and bariatric surgery (MBS) has been well studied. However, the effects of MBS on parathyroid function remain unclear.

Objective: The objective of this study was to perform a meta-analysis to examine the impact of MBS on the risk of secondary hyperparathyroidism (SHPT).

Setting: The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Methods: The PubMed, Embase, Web of Science, and the Cochrane Library databases were systematically reviewed from inception to May 2022 to identify studies reporting quantitative measurements of SHPT risk pre-MBS and post-MBS. Odds ratios (ORs) with 95% confidence intervals (95% CIs) were estimated and compared. Effects were pooled using a random-effects or fixed-effects model. Subgroup analyses were performed according to the follow-up time and surgical procedure.

Results: The final meta-analysis included 9 studies with a total of 5585 patients. The mean follow-up time was 3.5 years (range 0.25-5). Overall, MBS appears to does not affect SHPT risk (OR = 1.34, 95% CI 0.81-2.20, I = 95%). Follow-up data showed no evidence of SHPT within 2 years following gastric bypass (GB) and sleeve gastrectomy procedures (OR = 1.42, 95% CI 0.66-3.07 for GB, OR = 0.39, 95% CI 0.09-1.62 for sleeve gastrectomy ). At the 2-year and long-term follow-up intervals, a marked increase in SHPT was detected for GB (OR = 6.06, 95% CI 3.39-10.85 for GB). In addition, the surgical procedure for GB decreased the likelihood of SHPT compared with the surgical procedure for biliopancreatic diversion with duodenal switch (OR = 0.29, 95% CI 0.17-0.49).

Conclusions: Our meta-analysis indicated that GB appears to increase SHPT risk. Patients undergoing MBS should be aware of the risk of SHPT. Larger studies are needed to evaluate the outcomes and side effects and may eventually provide a better and more comprehensive understanding of the risks.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soard.2022.09.013DOI Listing

Publication Analysis

Top Keywords

shpt risk
12
bariatric surgery
8
secondary hyperparathyroidism
8
95%
8
follow-up time
8
sleeve gastrectomy
8
increase shpt
8
surgical procedure
8
shpt
7
risk
6

Similar Publications

Background: Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD) that affects approximately 90% of end-stage renal disease and poses a significant threat to long-term survival and quality of life in patients.

Objectives: To assess whether radiofrequency ablation (RFA) is a productive and low-risk treatment for hyperparathyroidism secondary to CKD.

Methods: Embase, Web of Science, Cochrane Library, and PubMed were searched independently by two authors.

View Article and Find Full Text PDF

Using machine learning models for predicting monthly iPTH levels in hemodialysis patients.

Comput Methods Programs Biomed

November 2024

Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. Electronic address:

Background And Objective: Intact parathyroid hormone (iPTH), also known as active parathyroid hormone, is an important indicator commonly for monitoring secondary hyperparathyroidism (SHPT) in patients undergoing hemodialysis. The aim of this study was to use machine learning (ML) models to predict monthly iPTH levels in patients undergoing hemodialysis.

Methods: We conducted a retrospective study on patients undergoing regular hemodialysis.

View Article and Find Full Text PDF
Article Synopsis
  • Secondary hyperparathyroidism (sHPT) is common in chronic kidney disease (CKD) patients, with many developing tertiary hyperparathyroidism (tHPT) after kidney transplantation.
  • A meta-analysis of 12 studies investigated how parathyroidectomy (surgery to remove the parathyroid glands) affects kidney graft function one year after the procedure.
  • Results showed a decline in kidney function, indicated by lower glomerular filtration rate and higher serum creatinine levels, suggesting that while calcium and parathyroid hormone levels normalized, the risk of graft loss increases after parathyroidectomy.
View Article and Find Full Text PDF

Objective: To identify the risk factors of postoperative severe hyperkalemia after total parathyroidectomy (TPTX) without auto-transplantation in patients with secondary hyperparathyroidism (SHPT).

Methods: Data on 406 consecutive patients who underwent TPTX without auto-transplantation for secondary hyperparathyroidism at the General Hospital of Northern Theater Command between January 2013 and January 2023, were prospectively collected. Then, patients were divided into the training set (n=203) and the validation set (n=203) in a ratio of 1:1 by timeline.

View Article and Find Full Text PDF
Article Synopsis
  • Secondary hyperparathyroidism (SHPT) is linked to bone metabolism issues and potential fracture risks, but there's debate about how parathyroid hormone (PTH) levels relate to these fractures.
  • A study of 180,333 hemodialysis patients found that higher baseline PTH levels, particularly for hip fractures, increased overall fracture risk, especially in older individuals and those with lower body mass index (BMI).
  • The research indicates that lower PTH levels correspond to reduced fracture risk, suggesting future studies should explore the effects of controlling PTH levels on fracture prevention.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!